IFP Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

IFP Advisors’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-307	Closed	-$8.44K	–	4954
2025 Q1	$8.44K	Hold	307	–	–	﹤0.01%	2640
2024 Q4	$8.28K	Hold	307	–	–	﹤0.01%	2603
2024 Q3	$8.85K	Hold	307	–	–	﹤0.01%	2471
2024 Q2	$8.36K	Hold	307	–	–	﹤0.01%	2403
2024 Q1	$8.6K	Hold	307	–	–	﹤0.01%	2289
2023 Q4	$8.17K	Hold	307	–	–	﹤0.01%	2260
2023 Q3	$7.85K	Hold	307	–	–	﹤0.01%	2347
2023 Q2	$8.04K	Hold	307	–	–	﹤0.01%	2370
2023 Q1	$6.6K	Hold	307	–	–	﹤0.01%	2462
2022 Q4	$7K	Hold	307	–	–	﹤0.01%	3598
2022 Q3	$7K	Sell	307 -285	-48%	-$7.37K	﹤0.01%	3850
2022 Q2	$13K	Hold	592	–	–	﹤0.01%	3186
2022 Q1	$13K	Buy	592 +277	+88%	+$7.15K	﹤0.01%	3186
2021 Q4	$9K	Hold	315	–	–	﹤0.01%	2268
2021 Q3	$8K	Hold	315	–	–	﹤0.01%	2367
2021 Q2	$8K	Hold	315	–	–	﹤0.01%	2292
2021 Q1	$8K	Hold	315	–	–	﹤0.01%	2221
2020 Q4	$8K	Hold	315	–	–	﹤0.01%	2147
2020 Q3	$8K	Hold	315	–	–	﹤0.01%	1984
2020 Q2	$7K	Buy	+315	New	+$6.98K	﹤0.01%	1946
2017 Q4	–	Sell	-200	Closed	-$4K	–	3904
2017 Q3	$4K	Hold	200	–	–	﹤0.01%	3501
2017 Q2	$4K	Hold	200	–	–	﹤0.01%	3498
2017 Q1	$4K	Buy	+200	New	+$3.9K	﹤0.01%	3405

Other funds holding FTXH

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return

WFA

WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return

VCM

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

IFP Advisors's FTXH Position: Q2 2025 in Review

IFP Advisors sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q2 2025, closing a stake of 307 shares — an estimated $8.44K sold.

IFP Advisors first reported a position in FTXH in Q1 2017 and held it in 23 quarters. The position peaked at $13K in Q2 2022. 18 funds tracked by Wall St. Rank hold FTXH as of Q2 2025.

IFP Advisors reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q2 2025 after selling out during the quarter.
IFP Advisors sold 307 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2025, an estimated $8.44K.
IFP Advisors first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q1 2017 and held it in 23 quarters.
IFP Advisors's First Trust Nasdaq Pharmaceuticals ETF position peaked at $13K in Q2 2022.
18 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2025.

Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.